Fáilte chuig an Institiúid um Leigheas Athghiniúnach
Welcome to the Regenerative Medicine Institute (REMEDI®)


Dr. Cathal Moran

Cathal is investigating novel mechanisms of MSC- based tissue engineering for the surgical repair of injured articular cartilage and meniscus.

View info >>

Dr. Mary Murphy

Lecturer in Regenerative Medicine & Director of Toxicology, REMEDI

The Biology, Mechanism of action and Use of adult stem cells for tissue regeneration in osteoarthritis.

View info >>

Seán Gaynard

The aim of this PhD project is to develop tissue engineering and cell therapy approaches for the treatment of critical size bone defects.

View info >>

Swarna Raman

Assessment of vIL-10 as a potential gene target for modulation of the immune environment

View info >>

Dr. Bill Curtin

Clinical Lecturer, Dept. of Surgery, NUI Galway & Consultant Orthopaedic Surgeon, UHG

Bill Curtin has major interests in surgery for hip and knee osteoarthritis, with a special interest in joint degeneration.

View info >>

Prof. Frank Barry

Scientific Director of REMEDI

The therapeutic application of adult stem cells, especially mesenchymal stem cells (MSCs) from bone marrow.

View info >>

Dr. Cynthia Coleman

Cynthia investigates the application of adult human bone marrow derived mesenchymal stem cells to treat osteoarthritis. The aim of her ongoing research is to assess the combination of mesenchymal stem cells (MSCs) and growth/differentiation factor 5 (GDF-5) as a potential therapeutic for arthritis, specifically focusing on the deposition of extracellular matrix proteins.

View info >>

Dr. Linda Howard

Linda investigates how microRNAs regulate the differentiation of MSCs.

Linda is also interested in the therapeutic potential of adult stem cells, particularly looking at the nervous, heart and musculoskeletal system.

View info >>

Niamh Fahy

Niamh aims to research the modulation of the inflammatory environment associated with Osteoarthritis.

View info >>

Dr. Jessica Hayes

Jessica's research is focusing on cell targeting for enhancing osteointegration in patients with reduced tissue regenerative capacity.

View info >>

Sharon Ansboro

Biomaterial strategies for targeted MSC delivery for cartilage repair in OA

View info >>